FDA poised to issue full approval for Pfizer vaccine

August 23, 2021
Sales and Marketing

The FDA is on track to issue full approval for its Pfizer vaccine. The New York Times reported that the Pfizer …

India approves world’s first DNA COVID vaccine

August 23, 2021
Sales and Marketing

Regulators in India have approved the world’s first DNA vaccine against COVID-19, ZyCoV-D, which has been developed by Cadila Healthcare.The …

Antibody tests offered to UK public for first time

August 23, 2021
Sales and Marketing

Antibody tests are to be made widely available to the public for the first time in a new government scheme …

fda_building_62

“You are not a cow” – FDA warns against using ivermectin to treat COVID

August 23, 2021
Sales and Marketing

The FDA has had to issue a warning against taking ivermectin, the anti-parasitic drug designed for livestock, to treat or …

COVID-19 boosters significantly lower infection risk, study in Israel finds

August 23, 2021
Sales and Marketing

A study in Israel has found that a third dose of the Pfizer COVID-19 vaccine significantly improved protection from infection …

Acting FDA Chief ruled out as permanent nominee

August 20, 2021
Medical Communications

The administration for US President, Joe Biden, has ruled out nominating Janet Woodcock as permanent head of the FDA, it …

roche__tree

UK approves “first of its kind” antibody cocktail for COVID-19

August 20, 2021
Medical Communications

The MHRA has approved a “first of its kind” antibody cocktail developed by Regeneron and Roche to prevent and treat …

UK COVID booster plan for over 50s may be scrapped

August 20, 2021
Medical Communications

Plans for a mass rollout of booster COVID vaccines for the over 50s this autumn may be shelved as the …

NICE broadens sapropterin guidance for treating phenylketonuria

August 20, 2021
Medical Communications

NICE has extended its approval of sapropterin (also called Kuvan and made by BioMarin) to pregnant women and people aged …

EU approves roxadustat for anaemia associated with chronic kidney disease

August 20, 2021
Medical Communications

Europe has approved Evrenzo (roxadustat) for patients with anaemia associated with symptomatic chronic kidney disease. Evrenzo is the first orally …

Prototype face mask can detect COVID-19 infection

August 19, 2021

A face mask has been designed by engineers at MIT and Harvard University that can diagnose the wearer with COVID-19 …

Cancer patients’ cells used in 3D-printed tumours

August 19, 2021

Researchers from Tel Aviv University have used brain cancer patients’ own cells in a form of 3D printing material to …

NICE launches public consultation on changes for health technology evaluation

August 19, 2021

NICE has launched a public consultation on proposed changes to the way it develops recommendations across its health technology evaluation …

Plague vaccine trial to start using AstraZeneca COVID jab tech

August 19, 2021

The University of Oxford has begun a Phase I trial using a plague vaccine based on the ChAdOx1 adenovirus viral …

UK study finds Pfizer and AstraZeneca jabs effective against Delta variant

August 19, 2021

A study led by Oxford University and the Office for National Statistics has found that the AstraZeneca COVID-19 vaccine, though …

Top UK medical cannabis firm acquires Spanish producer Sanoid

August 18, 2021
Research and Development

Grow Group, a UK medical cannabis firm, announced on Wednesday the acquisition of Sanoid Isolates, a key medical cannabis producer …

Sackler family refuse to pay billions for opioid crisis unless given immunity

August 18, 2021
Research and Development

The Sackler family, the billionaire owners of Purdue Pharma, vowed in court on Tuesday that unless they are granted legal …

Aspirin trialled as potential treatment for aggressive form of breast cancer

August 18, 2021
Research and Development

Aspirin is being trialled in combination with immunotherapy drugs as part of a potential new treatment for an aggressive form …

Bidding war for Australian mRNA vaccine production

August 18, 2021
Research and Development

Biotech company IDT has put forward a proposal to the Australian federal government to produce 100 million mRNA vaccines from …

Anger as NICE pauses advice on chronic fatigue syndrome therapy

August 18, 2021
Research and Development

NICE has paused publication of its updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome …

The Gateway to Local Adoption Series

Latest content